首頁 > 市場調查報告書 > 醫療設備

手術用器具

內視鏡逆行性胰造影（ERCP）市場規模、佔有率和成長分析（按產品類型、手術方式、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1897644

內視鏡逆行性胰造影（ERCP）市場規模、佔有率和成長分析（按產品類型、手術方式、最終用戶和地區分類）－2026-2033年產業預測

Endoscopic Retrograde Cholangiopancreatography Market Size, Share, and Growth Analysis, By Product Type (Endoscopes, Endotherapy Devices), By Procedure (Biliary Sphincterotomy, Biliary Stenting), By End Users, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月18日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球內視鏡逆行性造影(ERCP) 市場規模預計在 2024 年達到 16.5 億美元，從 2025 年的 18.1 億美元成長到 2033 年的 38.2 億美元，在預測期（2026-2033 年）內複合年成長率為 9.8%。

人們對微創手術技術的日益青睞推動了內視鏡逆行性造影術（ERCP）需求的成長，促進了市場擴張。 ERCP手術量的成長主要歸功於其諸多優勢，例如與傳統手術相比，恢復期更短、併發症率更低。此外，肝癌等疾病的日益普及也凸顯了對先進診斷和治療方案的迫切需求。隨著醫療技術的不斷創新，ERCP市場預計將迎來顯著成長，這反映了醫療實踐朝著更有效、更微創的方向發展，這些實踐優先考慮患者療效並提高整體醫療效率。

全球內視鏡逆行性胰造影（ERCP）市場促進因素

全球內視鏡逆行性造影(ERCP) 市場成長的驅動力在於，人們對胰臟、肝臟、膽囊和膽管疾病的先進診斷和治療方案的需求不斷成長。這項創新技術結合了內視鏡和透視技術，使醫療專業人員能夠有效地觀察和治療影響胰膽系統的疾病。 ERCP 使用軟性照明內視鏡並結合 X 光成像，可對這些重要器官進行詳細評估，進而改善治療效果。透過微創方式診斷和治療複雜疾病的能力，正促使越來越多的醫療機構採用這項技術，從而推動市場成長和擴張。

限制全球內視鏡逆行性胰造影（ERCP）市場的因素

全球內視鏡逆行性造影(ERCP) 市場的成長面臨許多挑戰，主要原因是各國監管機構實施了嚴格的指導方針。這些法規阻礙了創新技術的應用，因為合規性需要進行廣泛的測試並嚴格遵守安全性和有效性標準。因此，新醫療設備的核准流程複雜且耗時。儘管有這些監管限制，市場也受到一些正面因素的影響。例如，開發中國家可支配收入的成長是推動市場成長的主要因素，這有助於提高醫療保健服務的可近性並改善整體醫療保健效果。

全球內視鏡逆行性胰造影（ERCP）市場趨勢

全球內視鏡逆行性胰造影（ERCP）市場預計將迎來顯著成長，這主要得益於主要企業的策略性舉措。主要市場參與企業正致力於推出創新產品、建立合作關係、進行併購活動，旨在拓展產品線並改善患者預後。例如，一家專注於止血解決方案的科技公司與一家成熟的內視鏡設備製造商之間的合作，凸顯了各方致力於推進治療方法發展的決心。這一趨勢反映了醫療保健領域正朝著整合尖端技術、促進跨領域合作的方向發展，最終目標是提高消化器官系統介入手術的效率和安全性。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Olympus Corporation（Japan）
CONMED Corporation（United States）
Fujifilm Holdings Corporation（Japan）
HOYA Corporation（Japan）
Boston Scientific Corporation（United States）
Johnson & Johnson（United States）
Medtronic PLC（Ireland）
Cook Medical（United States）
STERRIS PLC（United States）
TeleMed Systems Inc.（United States）
DCC Healthcare（Medi-Globe GmbH）（Ireland）
Huger Medical Instrument Co. Ltd（China）
SonoScape Medical Corporation（China）
KARL STORZ SE & Co. KG（Germany）
Ambu A/S（Denmark）
B. Braun Melsungen AG（Germany）
PENTAX Medical（Japan）
Hitachi Ltd.（Japan）
Canon Medical Systems Corporation（Japan）
Sony Corporation（Japan）

結論與建議

簡介目錄

Product Code: SQMIG35A2748

Global Endoscopic Retrograde Cholangiopancreatography Market size was valued at USD 1.65 Billion in 2024 and is poised to grow from USD 1.81 Billion in 2025 to USD 3.82 Billion by 2033, growing at a CAGR of 9.8% during the forecast period (2026-2033).

The growing preference for minimally invasive surgical techniques is driving an increased demand for endoscopic retrograde cholangiopancreatography (ERCP) procedures, leading to a burgeoning market. This rise in ERCP interventions is largely attributed to the benefits associated with these approaches, including shorter recovery times and a lower incidence of complications relative to traditional surgeries. Moreover, the increasing prevalence of conditions like liver cancer underscores the urgent requirement for advanced diagnostic and therapeutic options. As healthcare continues to innovate, the ERCP market is positioned for substantial growth, reflecting a broader trend towards more effective and less invasive medical practices that prioritize patient outcomes and enhance overall healthcare efficiency.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Endoscopic Retrograde Cholangiopancreatography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Endoscopic Retrograde Cholangiopancreatography Market Segments Analysis

Global Endoscopic Retrograde Cholangiopancreatography Market is segmented by Product Type, Procedure, End Users and region. Based on Product Type, the market is segmented into Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices and Others. Based on Procedure, the market is segmented into Biliary Sphincterotomy, Biliary Stenting, Biliary Dialtation, Pancreatic Sphincterotomy, Pancreatic Duct Stenting and Pancreatic Duct Dilatation. Based on End Users, the market is segmented into Hospitals, Ambulatory Surgery Centers & Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Endoscopic Retrograde Cholangiopancreatography Market

The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) market is driven by the increasing demand for advanced diagnostic and therapeutic solutions targeting disorders of the pancreas, liver, gallbladder, and bile ducts. This innovative technique combines endoscopic and fluoroscopic methods, allowing healthcare professionals to visualize and treat conditions affecting the pancreatobiliary system effectively. By employing a flexible, illuminated endoscope alongside X-ray imaging, ERCP provides a detailed assessment of these critical organs, enhancing treatment outcomes. The ability to diagnose and manage complex maladies with a minimally invasive approach is attracting more healthcare facilities to adopt this technology, thereby fueling market growth and expansion.

Restraints in the Global Endoscopic Retrograde Cholangiopancreatography Market

The growth of the global endoscopic retrograde cholangiopancreatography market faces significant challenges due to strict regulatory guidelines enforced by governing bodies in various countries. These regulations create obstacles for the introduction of innovative technologies, as compliance demands extensive testing and strict adherence to safety and efficacy standards. This results in a complicated and lengthy approval process for new medical devices. Despite these regulatory constraints, there are positive influences on the market, including an increase in disposable income in developing countries, which has become a key driver of market growth, fostering greater accessibility and improving overall healthcare outcomes.

Market Trends of the Global Endoscopic Retrograde Cholangiopancreatography Market

The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) market is poised for substantial growth driven by strategic initiatives from leading players. Key industry participants are focusing on innovative product launches, partnerships, mergers, and acquisitions to enhance their offerings and improve patient outcomes. Collaborative ventures, such as those between technology firms specializing in hemostasis solutions and established endoscopic equipment manufacturers, underscore a commitment to advancing treatment methodologies. This trend reflects a broader movement within the healthcare sector towards integrating cutting-edge technologies and fostering collaboration, ultimately aiming to optimize procedural efficiency and enhance the safety of gastrointestinal interventions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies

Global Endoscopic Retrograde Cholangiopancreatography Market Size by Product Type & CAGR (2026-2033)

Market Overview
Endoscopes
Endotherapy Devices
- Sphincterotomes
- Lithotripter
- Stents
- Cannulas
- Forceps
- Snares
- Catheters
- Guiding Wires
- Balloons
- Baskets
Visualization Systems
Energy Devices
Others

Global Endoscopic Retrograde Cholangiopancreatography Market Size by Procedure & CAGR (2026-2033)

Market Overview
Biliary Sphincterotomy
Biliary Stenting
Biliary Dialtation
Pancreatic Sphincterotomy
Pancreatic Duct Stenting
Pancreatic Duct Dilatation

Global Endoscopic Retrograde Cholangiopancreatography Market Size by End Users & CAGR (2026-2033)

Market Overview
Hospitals
Ambulatory Surgery Centers & Clinics
Others

Global Endoscopic Retrograde Cholangiopancreatography Market Size & CAGR (2026-2033)

North America (Product Type, Procedure, End Users)
- US
- Canada
Europe (Product Type, Procedure, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Procedure, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Procedure, End Users)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Procedure, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CONMED Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HOYA Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STERRIS PLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TeleMed Systems Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DCC Healthcare (Medi-Globe GmbH) (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Huger Medical Instrument Co. Ltd (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SonoScape Medical Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KARL STORZ SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ambu A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PENTAX Medical (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hitachi Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canon Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sony Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments